Cargando…

FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma

BACKGROUND: The role of FDG-PET/CT imaging in assessing response to immunotherapy in advanced cutaneous squamous cell carcinoma (CSCC) is unknown. This study compared complete metabolic response (CMR) rates by FDG-PET and RECIST1.1 via CT or MRI in patients on cemiplimab for > 10 months. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	McLean, Luke S., Cavanagh, Karda, Hicks, Rodney J., Callahan, Jason, Xie, Jing, Cardin, Anthony, Lim, Annette M., Rischin, Danny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515684/ https://www.ncbi.nlm.nih.gov/pubmed/34645517 http://dx.doi.org/10.1186/s40644-021-00426-2

Ejemplares similares

Delayed Response After Confirmed Progression (DR) and Other Unique Immunotherapy-Related Treatment Concepts in Cutaneous Squamous Cell Carcinoma
por: Lim, Annette M., et al.
Publicado: (2021)

Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma
por: McLean, Luke S., et al.
Publicado: (2022)

Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma
por: Thai, Alesha A., et al.
Publicado: (2021)

Beyond FDG: novel PET tracers for cancer imaging
por: Hicks, Rodney J
Publicado: (2003)

How We Read Oncologic FDG PET/CT
por: Hofman, Michael S., et al.
Publicado: (2016)

The role of (18)F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!
por: Hung, Te-Jui, et al.
Publicado: (2019)

Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CT
por: Pattison, David A., et al.
Publicado: (2019)

Overview of early response assessment in lymphoma with FDG-PET
por: MacManus, Michael P, et al.
Publicado: (2007)

White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolism
por: Hofman, Michael S, et al.
Publicado: (2011)

Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation Therapy
por: MacManus, Michael P., et al.
Publicado: (2020)

Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients
por: Quak, Elske, et al.
Publicado: (2015)

Utility of dual time point 18 FDG PET-CT
por: De Luca, SE, et al.
Publicado: (2014)

(18)F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma
por: Wong, Annie, et al.
Publicado: (2020)

Reply to: The diagnostic accuracy of (18)F-FDG PET in cutaneous malignant melanoma
por: Delgado-Bolton, Roberto C., et al.
Publicado: (2010)

Active herpes zoster infection with cutaneous manifestation and adenopathy on FDG PET/CT
por: Wadih, Antoine, et al.
Publicado: (2015)

Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients
por: Kudura, Ken, et al.
Publicado: (2021)

Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma
por: Weppler, Alison M, et al.
Publicado: (2020)

The clinical significance and management of lesion motion due to respiration during PET/CT scanning
por: Callahan, Jason, et al.
Publicado: (2011)

Ruptured epidermal cyst mimicking cutaneous melanoma on F-18 FDG PET/CT
por: Nguyen, Ba D., et al.
Publicado: (2015)

FDG PET/CT in a rare case of multiple cutaneous metastases in carcinoma larynx
por: Jain, Anurag, et al.
Publicado: (2012)

Cutaneous Metastase of Rectal Neuroendocrine Carcinoma Revealed on (18)F-FDG PET/CT
por: Şahin, Ömer Faruk, et al.
Publicado: (2023)

The role of (18)F-FDG PET/CT in primary cutaneous lymphoma: an educational review
por: McDonald, Elysia O., et al.
Publicado: (2023)

A prospective investigation into the clinical impact of 4D-PET/CT in the characterisation of solitary pulmonary nodules
por: Callahan, Jason, et al.
Publicado: (2014)

The utility of (18) F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification
por: Cochet, Alexandre, et al.
Publicado: (2014)

Dual time point imaging of FDG PET/CT in a tuberculous spondylodiscitis
por: Abdul, HR, et al.
Publicado: (2010)

FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature
por: Aide, Nicolas, et al.
Publicado: (2018)

(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
por: Chang, Chian A., et al.
Publicado: (2016)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Tracking Actomyosin at Fluorescence Check Points
por: Lard, Mercy, et al.
Publicado: (2013)

Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
por: Roccuzzo, Gabriele, et al.
Publicado: (2021)

Dual-time-point FDG PET/CT imaging in prosthetic heart valve endocarditis
por: Scholtens, A. M., et al.
Publicado: (2017)

Follow up results of a prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer
por: Ng, Sweet Ping, et al.
Publicado: (2017)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

The role of PET in monitoring therapy
por: Hicks, Rodney J
Publicado: (2005)

Incidence and factors associated with cutaneous immune-related adverse events to immune check point inhibitors: An ambispective cohort study
por: Luangnara, Athitaya, et al.
Publicado: (2022)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

FDG-PET of Takayasu’s Arteritis
por: Shikino, Kiyoshi, et al.
Publicado: (2014)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

FDG-PET and colon cancer
por: Miles, Ken
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qipegs0qn9795ms88flrn90rlm